SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-082345
Filing Date
2014-03-04
Accepted
2014-03-04 16:30:09
Documents
2
Period of Report
2014-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d683625d8k.htm 8-K 15364
2 EX-10.35 d683625dex1035.htm EX-10.35 36703
  Complete submission text file 0001193125-14-082345.txt   53149
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 14665058
SIC: 2834 Pharmaceutical Preparations